{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:31:24Z","timestamp":1784259084997,"version":"3.55.0"},"reference-count":108,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2011,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The discovery of the human immunodeficiency virus type 1 (HIV-1) in 1982 soon led to the identification and development of antiviral compounds to be used in treatment strategies for infected patients. Early in the epidemic, drug monotherapies frequently led to treatment failures because the virus quickly developed resistance to the single drug. Following the advent of highly active antiretroviral therapy (HAART) in 1995, dramatic improvements in HIV-1-infected patient health and survival were realized as more refined combination therapies resulted in reductions in viral loads and increases in CD4<jats:sup>+<\/jats:sup>T-cell counts. In the absence of an effective vaccine, prevention of HIV-1 infection has also gained traction as an approach to curbing the pandemic. The development of compounds as safe and effective microbicides has intensified and has focused on blocking the transmission of HIV-1 during all forms of sexual intercourse. Initial preclinical investigations and clinical trials of microbicides focused on single compounds effective against HIV-1. However, the remarkable successes achieved using combination therapy to treat systemic HIV-1 infection have subsequently stimulated the study and development of combination microbicides that will simultaneously inhibit multiple aspects of the HIV-1 transmission process by targeting incoming viral particles, virus-infected cells, and cells susceptible to HIV-1 infection. This review focuses on existing and developing combination therapies, covering preclinical development,<jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">in vitro<\/jats:named-content>and<jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">in vivo<\/jats:named-content>efficacy studies, and subsequent clinical trials. The shift in focus within the microbicide development field from single compounds to combination approaches is also explored.<\/jats:p>","DOI":"10.1128\/aac.00976-10","type":"journal-article","created":{"date-parts":[[2011,2,23]],"date-time":"2011-02-23T04:16:50Z","timestamp":1298434610000},"page":"1831-1842","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":90,"title":["Combinatorial Approaches to the Prevention and Treatment of HIV-1 Infection"],"prefix":"10.1128","volume":"55","author":[{"given":"Vanessa","family":"Pirrone","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology and Institute for Molecular Medicine and Infectious Disease, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102"},{"name":"Center for Sexually Transmitted Disease, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102"},{"name":"Center for Molecular Therapeutics and Resistance, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Thakkar","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology and Institute for Molecular Medicine and Infectious Disease, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102"},{"name":"Center for Sexually Transmitted Disease, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102"},{"name":"Center for Molecular Therapeutics and Resistance, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Jacobson","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology and Institute for Molecular Medicine and Infectious Disease, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102"},{"name":"Center for Sexually Transmitted Disease, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102"},{"name":"Center for Molecular Therapeutics and Resistance, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102"},{"name":"Center for Clinical and Translational Medicine, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102"},{"name":"Department of Medicine, Division of Infectious Diseases and HIV Medicine, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Wigdahl","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology and Institute for Molecular Medicine and Infectious Disease, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102"},{"name":"Center for Sexually Transmitted Disease, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102"},{"name":"Center for Molecular Therapeutics and Resistance, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred C.","family":"Krebs","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology and Institute for Molecular Medicine and Infectious Disease, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102"},{"name":"Center for Sexually Transmitted Disease, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102"},{"name":"Center for Molecular Therapeutics and Resistance, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(87)90440-0"},{"key":"e_1_3_3_3_2","unstructured":"AIDS Clinical Trials Group. 1993. Executive summary for ACTG 155. AIDS Clinical Trials Group Bethesda Maryland."},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1995.11.533"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.4.726"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.1.245-247.2002"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.10.5698"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199810000-00004"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60202-5"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/41.1.59"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/44.1.65"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi970140u"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.2.358"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-7348.1939.tb06990.x"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.59.5.949"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.7.1521"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(08)60674-4"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1080\/21548331.1994.11443111"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/18.4.516"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/168.2.318"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199502000-00005"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.2174\/1568005023342380"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1980.tb06155.x"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(83)90490-X"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0065-2571(84)90007-4"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1E030"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7824947"},{"key":"e_1_3_3_28_2","unstructured":"CohenJ. 14 December 2009 posting date. HIV outwits yet another microbicide. Sci. Now. http:\/\/news.sciencemag.org\/sciencenow\/2009\/12\/14-01.html?ref=hp."},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-119-8-199310150-00003"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.11.4721-4732.2005"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.090576697"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.5.1127"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.7.1559"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.5.4360-4371.1999"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.02.059"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1319"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.olq.0000223287.46097.4b"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-7348.1942.tb06923.x"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-118-10-199305150-00002"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/nsb0498-276"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2007.03.004"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200309260-00005"},{"key":"e_1_3_3_43_2","first-page":"635","article-title":"The employment of combinations of drugs in the chemotherapy of neoplasia: a review","volume":"17","author":"Goldin A.","year":"1957","unstructured":"GoldinA. MantelN.. 1957. The employment of combinations of drugs in the chemotherapy of neoplasia: a review. Cancer Res. 17:635\u2013654.","journal-title":"Cancer Res"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.15.6863"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0803152"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003784"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1086\/597290"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.24.1984"},{"key":"e_1_3_3_49_2","first-page":"1","article-title":"Something new under the sun. Maraviroc poised for approval","volume":"20","author":"Huff B.","year":"2006","unstructured":"HuffB. 2006. Something new under the sun. Maraviroc poised for approval. GMHC Treat. Issues 20:1\u20134.","journal-title":"GMHC Treat. Issues"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1086\/315698"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/164.4.646"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1089\/088922203763315678"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/3293"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri1848"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.5.1830-1836.2005"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2009.02.022"},{"key":"e_1_3_3_57_2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0031-6997(25)07221-7","article-title":"Antagonisms and antagonists","volume":"9","author":"Loewe S.","year":"1957","unstructured":"LoeweS. 1957. Antagonisms and antagonists. Pharmacol. Rev. 9:237\u2013242.","journal-title":"Pharmacol. Rev"},{"key":"e_1_3_3_58_2","first-page":"285","article-title":"The problem of synergism and antagonism of combined drugs","volume":"3","author":"Loewe S.","year":"1953","unstructured":"LoeweS. 1953. The problem of synergism and antagonism of combined drugs. Arzneimittelforschung 3:285\u2013290.","journal-title":"Arzneimittelforschung"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.8.5087-5094.1995"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(95)02230-9"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.3109\/14756369209041357"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1701568"},{"key":"e_1_3_3_63_2","unstructured":"Microbicide Trials Network. 2009. MTN fact sheet: HPTN 035 at a glance. Microbicide Trials Network Pittsburgh PA. http:\/\/www.mtnstopshiv.org\/news\/studies\/hptn035\/facts."},{"key":"e_1_3_3_64_2","unstructured":"Microbicide Trials Network. 2009. Trial finds microbicide promising as HIV prevention method for women. Microbicide Trials Network Pittsburgh PA. http:\/\/www.mtnstopshiv.org\/node\/765."},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.6.1911"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.3.664-672.2001"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/40.6.765"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1086\/319284"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.1.23-31.1995"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1994.10.1479"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-2-6"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-6-150"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-1-17"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.5.4145-4155.1999"},{"key":"e_1_3_3_75_2","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. 2009. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services Washington DC. http:\/\/www.aidsinfo.nih.gov\/ContentFiles\/Adultand AdolescentsGL.pdf."},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/548749"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.2174\/1568005014606044"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1990.tb17823.x"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.3.540"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(90)90001-N"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-2-S1-S96"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198707233170402"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.68.3.1660-1666.1994"},{"key":"e_1_3_3_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2006.05.016"},{"key":"e_1_3_3_85_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199608010-00006"},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00176a005"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61842-5"},{"key":"e_1_3_3_88_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.3500514"},{"key":"e_1_3_3_89_2","doi-asserted-by":"publisher","DOI":"10.1002\/stem.5530060603"},{"key":"e_1_3_3_90_2","doi-asserted-by":"publisher","DOI":"10.1002\/jso.2930370304"},{"key":"e_1_3_3_91_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.221375398"},{"key":"e_1_3_3_92_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm800245z"},{"key":"e_1_3_3_93_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-199912150-00002"},{"key":"e_1_3_3_94_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.5.1336-1339.2002"},{"key":"e_1_3_3_95_2","doi-asserted-by":"publisher","DOI":"10.1089\/088922203322230897"},{"key":"e_1_3_3_96_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.9.5201-5208.2003"},{"key":"e_1_3_3_97_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11079-8"},{"key":"e_1_3_3_98_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e318159d5a8"},{"key":"e_1_3_3_99_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200305020-00007"},{"key":"e_1_3_3_100_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690452"},{"key":"e_1_3_3_101_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm833"},{"key":"e_1_3_3_102_2","first-page":"339","article-title":"Synergism and potentiation with special reference to the combination of structural analogues","volume":"8","author":"Veldstra H.","year":"1956","unstructured":"VeldstraH. 1956. Synergism and potentiation with special reference to the combination of structural analogues. Pharmacol. Rev. 8:339\u2013387.","journal-title":"Pharmacol. Rev"},{"key":"e_1_3_3_103_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.63.1.203"},{"key":"e_1_3_3_104_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200411050-00003"},{"key":"e_1_3_3_105_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.104.002626"},{"key":"e_1_3_3_106_2","unstructured":"WarrenM. MarshallK.. 2009. AVAC statement on MDP 301. Press release 14 December 2009. AIDS Vaccine Advisory Coalition New York NY. http:\/\/www.hivvaccineenterprise.org\/sites\/default\/files\/avac%20statement%20on%20MPD%20301%20dec%2014.pdf."},{"key":"e_1_3_3_107_2","doi-asserted-by":"crossref","unstructured":"WebbJ. L. 1963. Enzyme and metabolic inhibitors. Academic Press New York NY.","DOI":"10.5962\/bhl.title.7320"},{"key":"e_1_3_3_108_2","unstructured":"WoolleyD. W. 1952. A study of antimetabolites. Wiley New York NY."},{"key":"e_1_3_3_109_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90283-8"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00976-10","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00976-10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T22:41:57Z","timestamp":1740955317000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00976-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":108,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["10.1128\/AAC.00976-10"],"URL":"https:\/\/doi.org\/10.1128\/aac.00976-10","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"2011-04-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}